Home Products Services Projects Partners FAQ Contacts About Us
Mobetron
 

Key Benefits

  1. Worldwide sales and service centers in North America, Europe, Asia and Southern Africa
  2. More cost-effective IORT treatment with strong ROI and best quality care
  3. Treat a variety of solid tumor cancers safely and quickly with reduced risk of infection to patients
  4. Greater patient availability and simpler logistics to treat patients
  5. Small, mobile and lightweight allowing system to be shared between multiple OR’s
  6. No additional shielding required in ORs
Description

IntraOp’s Mobetron is the world’s first mobile, self-shielded, electron linear accelerator, which delivers IntraOperative RadioTherapy (IORT) to patients as they are undergoing cancer surgery, safely and quickly in non-shielded operating rooms (OR).

IORT is used to treat a variety of solid tumor cancers. More than 15,000 patients have received IORT as part of their cancer treatment. Whether a particular cancer will benefit from IORT treatment will depend on several factors, including, but not limited to, the stage of the tumor, the tumor resectability, the extent of the disease, and any previous treatment which may have been received. For any particular tumor, it is essential to discuss the merits of including IORT as part of the cancer treatment program with an experienced oncologist.

Applications / Clinical Data
  1. Locally Advanced Rectal Cancer
  2. Basal and Squamous Cell Carcinoma
  3. Breast - Bio Boost
  4. Breast - Single Dose
  5. Head/Neck
  6. Pancreatic
  7. Retroperitoneal Sarcomas
  8. Skin Cancer
  9. Soft Tissue Sarcomas

As a patient dealing with the life changing challenges that cancer can bring, awareness of the latest technologies and best health care are critical factors. IOERT and the Mobetron offer a superior approach to treating cancer using proven technology, backed by countless success stories. Currently there is no other treatment available that comes close to offering the same level of tumor eradication, recurrence reduction, and preservation of quality of life.

IOERT and the Mobetron are bringing new hope for breast cancer patients by allowing surgeons and radiation oncologists to give a dose of radiation at the time of surgery. This additional radiation has been shown in clinical uses to reduce patient recurrent rates significantly. In addition, IOERT can reduce the need for post operative radiation, allowing the patient to begin the healing process.

The benefits of IOERT and Mobetron use extend to surgeons and radiation oncologists as well. The Mobetron offers the professional caregiver the opportunity to offer the best quality of care to his or her patients, while also offering a very powerful practice-building tool. By being a provider of this technology, professionals who use the Mobetron are able to offer a unique and highly effective level of care that will help them to provide the best possible care to their patients.

Contact Us for pricing
 
Instrusoft Engineering © 2010. All rights reserved | Privacy Policy